Cases 51 - 60 of 917
1199SEIU NATIONAL BENEFIT FUND et al v. ACTAVIS HOLDCO US, INC. et al
as 2:2018cv02401
Defendant:
HERITAGE PHARMACEUTICALS, INC., PLIVA, INC., SANDOZ, INC. and others
Plaintiff:
1199SEIU NATIONAL BENEFIT FUND, SERGEANTS BENEVOLENT ASSOCIATON OF THE POLICE DEPARTMENT OF THE CITY OF NEW YORK HEALTH AND WELFARE FUND, SELF-INSURED SCHOOLS OF CALIFORNIA and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
SEIFERT v. MYLAN PHARMACEUTICALS INC. et al
as 1:2022cv06727
Plaintiff:
Donald Seifert
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
OLIVER v. MYLAN LABORATORIES LTD. et al
as 1:2022cv06532
Plaintiff:
PETER T. OLIVER
Defendant:
MYLAN LABORATORIES, LTD., MYLAN N.V., MYLAN PHARMACEUTICALS, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BAKER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06466
Plaintiff:
DERWIN BAKER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01226
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ENANDER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06383
Plaintiff:
MARK ENANDER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HARDWICK v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06397
Plaintiff:
DIANE HARDWICK
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MOTTIE v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06304
Plaintiff:
MAURICE MOTTIE
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CARTER v. MYLAN N.V. et al
as 1:2022cv05561
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
JACQUELINE CARTER
Defendant:
MYLAN N.V., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SMITH v. MYLAN PHARMACEUTICALS INC. et al
as 1:2022cv06229
Plaintiff:
Deborah Smith
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
